What is GLPGF stock price today?

Visit our real-time dashboard for the current GLPGF stock price and live market data.

Is GLPGF stock going up or down today?

GLPGF stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy GLPGF stock now?

The decision to buy GLPGF depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is GLPGF a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for GLPGF based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is GLPGF stock overvalued or undervalued?

GLPGF currently trades at a P/E ratio of 5.70, which may suggest attractive valuation. Our DCF calculator provides intrinsic value estimates to help determine if GLPGF is fairly priced.

What is GLPGF's P/E ratio?

GLPGF has a price-to-earnings (P/E) ratio of 5.70, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is GLPGF's market cap?

GLPGF (Galapagos NV) has a market capitalization of $3.21 billion, making it a small-cap stock.

What is GLPGF's price to book ratio?

Price-to-book ratio for GLPGF is available on our dashboard along with other valuation metrics.

Does GLPGF pay dividends?

GLPGF does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is GLPGF's dividend yield?

GLPGF does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is GLPGF stock a good long-term investment?

GLPGF's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is GLPGF's revenue growth rate?

Revenue growth data for GLPGF is available on our dashboard with detailed financial statement analysis.

Profitability metrics for GLPGF are available on our dashboard with complete income statement analysis.

What are the risks of investing in GLPGF?

Key risks for GLPGF include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does GLPGF compare to its competitors?

Compare GLPGF to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize GLPGF's performance and positioning.

What is GLPGF's stock price target for 2026?

Visit our prediction page for AI-powered price targets for GLPGF with bull, base, and bear case scenarios.

What do analysts say about GLPGF?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for GLPGF. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is GLPGF's next earnings report?

GLPGF reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

GLPGF - Galapagos NV

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Galapagos NV

Galapagos NV (GLPGF) common stock

Price Chart

Loading chart...

GLPGF Key Statistics

Market Cap

$3.21B

P/E Ratio

5.70

How GLPGF Compares to Peers

GLPGF has the lowest P/E ratio in Biotechnology, suggesting it may be the most undervalued

GLPGF is the smallest among peers, which may offer higher growth potential

P/E Rank

of 6

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
GLPGF(This stock)	$3.21B	5.7	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: July 20, 2026 at 2:06 PM EDT

Ready to invest in GLPGF?

Commission-free trading available. Affiliate links.

Upcoming Events for GLPGF

Dashboard

Enter a ticker to analyze